BVF as of March 31, 2018
Portfolio Holdings for BVF
BVF holds 43 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Chemocentryx | 9.9 | $98M | 7.2M | 13.60 | |
| Ironwood Pharmaceuticals (IRWD) | 8.7 | $86M | 5.5M | 15.43 | |
| Array BioPharma | 8.4 | $83M | 5.1M | 16.32 | |
| Blueprint Medicines (BPMC) | 6.1 | $60M | 656k | 91.70 | |
| ArQule | 4.8 | $47M | 16M | 2.88 | |
| Syndax Pharmaceuticals (SNDX) | 4.7 | $46M | 3.2M | 14.23 | |
| Merus N V (MRUS) | 4.5 | $45M | 2.4M | 18.53 | |
| Concert Pharmaceuticals I equity | 4.5 | $44M | 1.9M | 22.90 | |
| Cytokinetics (CYTK) | 4.2 | $41M | 5.7M | 7.20 | |
| Anaptysbio Inc Common (ANAB) | 4.1 | $40M | 386k | 104.08 | |
| Xoma Corp Del (XOMA) | 3.1 | $30M | 1.5M | 20.23 | |
| Xencor (XNCR) | 2.7 | $27M | 902k | 29.98 | |
| Cti Biopharma | 2.7 | $27M | 6.9M | 3.90 | |
| Kura Oncology (KURA) | 2.6 | $25M | 1.4M | 18.75 | |
| Pieris Pharmaceuticals | 2.5 | $25M | 3.6M | 6.82 | |
| Biolinerx Ltd-spons | 2.3 | $23M | 26M | 0.87 | |
| Corvus Pharmaceuticals (CRVS) | 2.3 | $23M | 2.0M | 11.53 | |
| Infinity Pharmaceuticals (INFIQ) | 2.1 | $21M | 9.8M | 2.10 | |
| Arcus Biosciences Incorporated (RCUS) | 2.0 | $20M | 1.3M | 15.44 | |
| Spero Therapeutics (SPRO) | 1.5 | $15M | 1.0M | 14.25 | |
| Oncomed Pharmaceuticals | 1.4 | $14M | 4.3M | 3.18 | |
| Immune Design | 1.4 | $14M | 4.1M | 3.30 | |
| Erytech Pharma Sa | 1.3 | $13M | 625k | 21.00 | |
| Spring Bk Pharmaceuticals In | 1.3 | $13M | 832k | 15.38 | |
| Vbi Vaccines | 1.1 | $11M | 3.1M | 3.50 | |
| Gtx Inc Del | 1.1 | $11M | 610k | 17.75 | |
| Forward Pharma A/s | 1.1 | $10M | 4.8M | 2.17 | |
| Regulus Therapeutics | 1.0 | $10M | 14M | 0.72 | |
| Verastem | 0.8 | $8.2M | 2.7M | 2.98 | |
| Aduro Biotech | 0.8 | $7.5M | 807k | 9.30 | |
| Albireo Pharma | 0.7 | $7.3M | 225k | 32.57 | |
| Tocagen | 0.6 | $6.0M | 505k | 11.85 | |
| Contrafect | 0.6 | $5.6M | 3.5M | 1.59 | |
| Molecular Templates | 0.6 | $5.5M | 689k | 8.00 | |
| Alpine Immune Sciences | 0.6 | $5.4M | 676k | 8.00 | |
| Genocea Biosciences | 0.5 | $5.3M | 5.0M | 1.05 | |
| Sunesis Pharmaceuticals Inc Ne | 0.5 | $4.6M | 1.7M | 2.72 | |
| Xenon Pharmaceuticals (XENE) | 0.4 | $3.5M | 721k | 4.90 | |
| Protagonist Therapeutics (PTGX) | 0.3 | $3.5M | 406k | 8.59 | |
| Vical | 0.2 | $2.0M | 1.4M | 1.45 | |
| Essa Pharma | 0.2 | $1.9M | 10M | 0.19 | |
| Loxo Oncology | 0.1 | $506k | 4.4k | 115.37 | |
| Orexigen Therapeutics | 0.0 | $107k | 535k | 0.20 |
